These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37513675)

  • 21. Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Elastography to Evaluate the Early Effects of Bariatric Surgery on Nonalcoholic Fatty Liver Disease.
    Tan HC; Shumbayawonda E; Beyer C; Cheng LT; Low A; Lim CH; Eng A; Chan WH; Lee PC; Tay MF; Kin S; Chang JPE; Bee YM; Goh GBB
    Int J Biomed Imaging; 2023; 2023():4228321. PubMed ID: 37521027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis.
    Sanyal AJ; Ratziu V; Loomba R; Anstee QM; Kowdley KV; Rinella ME; Sheikh MY; Trotter JF; Knapple W; Lawitz EJ; Abdelmalek MF; Newsome PN; Boursier J; Mathurin P; Dufour JF; Berrey MM; Shiff SJ; Sawhney S; Capozza T; Leyva R; Harrison SA; Younossi ZM
    J Hepatol; 2023 Nov; 79(5):1110-1120. PubMed ID: 37517454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of biochemical and genomic pathways through lycopene-loaded nano-liposomes: Alleviating insulin resistance, hepatic steatosis, and autophagy in obese rats with non-alcoholic fatty liver disease: Involvement of SMO, GLI-1, and PTCH-1 genes.
    Salem GA; Mohamed AA; Khater SI; Noreldin AE; Alosaimi M; Alansari WS; Shamlan G; Eskandrani AA; Awad MM; El-Shaer RAA; Nassan MA; Mostafa M; Khamis T
    Gene; 2023 Oct; 883():147670. PubMed ID: 37516284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trajectories of Meat Intake and Risk of Type 2 Diabetes: Findings from the China Health and Nutrition Survey (1997-2018).
    Liu M; Wang H; Du S; Jiao Y; Wang Q; Su C; Zhang B; Ding G
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined with multiplex and network analysis to reveal the key genes and mechanisms of nonalcoholic fatty liver disease.
    Yang Z; Han X; Wang K; Fang J; Wang Z; Liu G
    Int Immunopharmacol; 2023 Oct; 123():110708. PubMed ID: 37523974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches.
    Giannoukakis N; McCommis KS
    Front Endocrinol (Lausanne); 2023; 14():1253604. PubMed ID: 37529604
    [No Abstract]   [Full Text] [Related]  

  • 27. Ultrasound LI-RADS Visualization Scores on Surveillance Ultrasound for Hepatocellular Carcinoma: A Systematic Review With Meta-analysis.
    Kang JH; Kim NH; Kim DH; Choi Y; Choi JI
    Ultrasound Med Biol; 2023 Oct; 49(10):2205-2212. PubMed ID: 37517886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD.
    Fernández-Sáez EM; Losarcos M; Becerril S; Valentí V; Moncada R; Martín M; Burrell MA; Catalán V; Gómez-Ambrosi J; Mugueta C; Colina I; Silva C; Escalada J; Frühbeck G; Rodríguez A
    Metabolism; 2023 Oct; 147():155663. PubMed ID: 37517791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of electronic-based lifestyle interventions on nonalcoholic fatty liver disease: A systematic review.
    Seifi N; Bahari H; Soltani S; Nikoumanesh M; Hajipoor M; Ferns GA; Ghayour-Mobarhan M
    Digit Health; 2023; 9():20552076231187597. PubMed ID: 37529544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Approach to Elevated Liver Enzymes.
    Rosenberg J; Sola O; Visconti A
    Prim Care; 2023 Sep; 50(3):363-376. PubMed ID: 37516508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dibenzocyclooctadiene lignans from the family Schisandraceae: A review of phytochemistry, structure-activity relationship, and hepatoprotective effects.
    Liu SQ; Yang YP; Hussain N; Jian YQ; Li B; Qiu YX; Yu HH; Wang HZ; Wang W
    Pharmacol Res; 2023 Sep; 195():106872. PubMed ID: 37516152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol Paradox in Older People with Type 2 Diabetes Mellitus Regardless of Lipid-Lowering Drug Use: A Cross-Sectional Cohort Study.
    Wang TY; Chang WL; Wei CY; Liu CH; Tzeng RC; Chiu PY
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice.
    Villani R; Magnati GP; Tuccari G; Sangineto M; Romano AD; Cassano T; Serviddio G
    Ultrasound; 2023 Aug; 31(3):177-185. PubMed ID: 37538971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between Thyroid Hormones and Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis in Obese Individuals Undergoing Bariatric Surgery.
    Ashraf Ganjooei N; Jamialahmadi T; Nematy M; Shah NZ; Jangjoo S; Emami N; Jangjoo A; Faridnia R; Alidadi M; Sathyapalan T; Sahebkar A
    Middle East J Dig Dis; 2022 Oct; 14(4):410-421. PubMed ID: 37547501
    [No Abstract]   [Full Text] [Related]  

  • 35. Follicle-stimulating hormone is negatively associated with nonalcoholic fatty liver disease in a Chinese elderly population: a retrospective observational study.
    Li X; Xin N; Guo T; Wu Z; Zheng Y; Lin L; Li Q; Lin F
    BMC Endocr Disord; 2023 Aug; 23(1):165. PubMed ID: 37550673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver fat as risk factor of hepatic and cardiometabolic diseases.
    Demir M; Bornstein SR; Mantzoros CS; Perakakis N
    Obes Rev; 2023 Oct; 24(10):e13612. PubMed ID: 37553237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review.
    Ng JJJ; Loo WM; Siah KTH
    World J Hepatol; 2023 Jul; 15(7):925-938. PubMed ID: 37547029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Non-Invasive Markers with Significant Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.
    Zhang F; Han Y; Zheng L; Liu J; Wu Y; Bao Z; Liu L; Li W
    Diabetes Metab Syndr Obes; 2023; 16():2255-2268. PubMed ID: 37545743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NIS2+™, an effective blood-based test for the diagnosis of at-risk nonalcoholic steatohepatitis in adults 65 years and older.
    Sanyal AJ; Magnanensi J; Majd Z; Rosenquist C; Vera DM; Almas JP; Connelly MA
    Hepatol Commun; 2023 Sep; 7(9):. PubMed ID: 37556372
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Ding M; Zhou F; Li Y; Liu C; Gu Y; Wu J; Fan G; Li Y; Li X
    Chin Herb Med; 2023 Jul; 15(3):421-429. PubMed ID: 37538867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.